Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Muscular Dystrophy-Induced Heart Failure Averted by Stem Cells.

Posted by devin@stemsave.com on Jan 2, 2015 7:59:49 AM

Although duchenne muscle dystrophy affects the entire body, often the cause of death for DMD patients is heart failure.

Researchers led by Eduardo Marbón of the Cedars-Sinai Heart Institute have developed a method to prolong the lives of patients with Duchenne Muscular Dystrophy [DMD] through the infusion of cardiac stem cells. The stem cells reverse the loss of cardiac muscle caused by the genetic disease, preventing heart failure that would otherwise limit a patient’s life expectancy to age 25.

Read More

Topics: Muscular Dystrophy, Heart, stemsaveblog, Heart Failure, Duchenne Muscular Dystrophy, Debilitating Diseases, Stemcells, Heart Attack, autologousstemcells, heart disease

Muscle Degeneration Halted by Stem Cell Activation

Posted by taylor@stemsave.com on Sep 26, 2014 10:46:53 AM

A protein involved in muscle regeneration may be integral in activating stem cell-mediated muscle repair.

Researchers at Sanford-Burnham Medical research institute have developed a potential method of regenerating autologous [the patient’s own] stem cells to repair damaged muscle tissue in patients suffering from muscle-degenerative diseases. The scientists found that the inhibition of protein STAT3 results in the replenishment of the body’s muscle stem cells, which in turn repair the muscles that are damaged by age, cancer, and diseases such as muscular dystrophy.

Read More

Topics: Muscular Dystrophy, Phase III, stemsaveblog, clinical trials, Duchenne Muscular Dystrophy, Debilitating Diseases, Stemcells, autologousstemcells

New York Times: The Eruption of Stem Cell Therapies.

Posted by taylor@stemsave.com on Sep 16, 2014 11:04:35 AM

Mr. Edgar Irastorza is one of thousands of people already benefiting from the progression of stem cell based therapies.

As reported on the front page of the New York Times Science section, clinical applications of stem cell based therapies are accelerating at a rate that will revolutionize the medical field in a matter of years. In the United States alone, there are currently over 4000 therapies in clinical trials for the treatment of heart disease, blindness, spinal cord injuries, diabetes, H.I.V., and other diseases, injuries, and traumas.

Read More

Topics: Muscular Dystrophy, ALS, Parkinson's, Phase III, multiple sclerosis, Heart, stemsaveblog, Joints, Alzheimer's, burn injuries, Diabetes, Acute Myocardial Infarction, Brain, Heart Failure, clinical trials, Bone, Debilitating Diseases, Phase II, Arthritis, Stemcells, Teeth, autologousstemcells, cartilage, Amyotrophic lateral sclerosis, Brain Tumors, Blindness

FSHD Study Utilizes Stem Cells

Posted by barb@stemsave.com on Sep 9, 2014 5:48:00 AM

A new potential treatment for FSHD utilizes stem cells to regenerate the muscle lost to protein DUX4.

In a recently published study by the University of Minnesota, researchers are utilizing skeletal muscle stem cells in an animal model designed to study the muscle-degenerative protein DUX4 found in patients with facioscapulohumeral muscular dystrophy [FSHD]. The team was able to harvest the muscle stem cells from one mouse with FSHD and transplant them into a recipient mouse, allowing the recipient to regenerate new muscle as long as DUX4 was not activated.

Read More

Topics: Muscular Dystrophy, stemsaveblog, Duchenne Muscular Dystrophy, Debilitating Diseases, Stemcells, autologousstemcells, Spinal Muscular Atrophy

Anti-Aging Properties of MSCs

Posted by anna@stemsave.com on Aug 1, 2014 5:54:37 AM

Mesenchymal Stem Cells are able to stimulate muscle-building cells that lose function with age.

A recently published study by University of Illinois Kinesiology and Community Health Professor Marni Boppart has identified mesenchymal stem cells [MSCs] as a tool for rejuvenating muscle to prevent age-related injuries and disabilities. In addition to their ability to differentiate into other cell types, MSCs were found to secrete growth factors that stimulate the activation of the multiple cell types comprising skeletal muscle, including muscle precursor cells and satellite cells, which lose function with age.

Read More

Topics: Muscular Dystrophy, Paralysis, stemsaveblog, clinical trials, Duchenne Muscular Dystrophy, Debilitating Diseases, Stemcells, autologousstemcells, Spinal Muscular Atrophy

Harnessing the Power of Stem Cells

Posted by hunter@stemsave.com on Jul 20, 2014 12:12:07 PM

Scientists have developed a method for increasing the survival rate, and therefore the effectiveness, of transplanted mesenchymal stem cells.

A team of scientists from the Harvard Stem Cell Institute and the Boston Children’s Hospital have developed a method to increase the survival rate, and therefore the effectiveness, of transplanted mesenchymal stem cells [MSCs]. In an animal model, Dr. Juan Melero-Martin and his team of researchers co-transplanted MSCs with blood vessel-forming cells, enabling the stem cells to survive longer in a patient to reach their full regenerative potential.

Read More

Topics: Muscular Dystrophy, Skin, neural stem cells, stemsaveblog, Heart Failure, Debilitating Diseases, Stemcells, autologousstemcells, dentalstemcells, dental pulp stem cells, young stem cells

Muscle Degeneration Reversed Through Discovery of Stem Cell Pathways

Posted by barb@stemsave.com on Apr 4, 2014 7:35:24 AM

A new discovery in stem cell differentiation could lead to new treatments for muscle-wasting diseases.

Recent research from the University of Colorado Boulder has identified two stem cell signaling pathways that are directly related to the age-related degeneration of muscle tissue and the onset of a variety of muscle-wasting diseases, such as muscular dystrophy and sarcopenia. By altering these pathways, the investigators were able to enhance muscle stem cell renewal and improve muscle regeneration.

Read More

Topics: Muscular Dystrophy, stemsaveblog, clinical trials, Duchenne Muscular Dystrophy, Debilitating Diseases, Stemcells, autologousstemcells, Spinal Muscular Atrophy

Stem Cells Utilized to Develop Treatments for Duchenne Muscular Dystrophy

Posted by hunter@stemsave.com on Oct 17, 2013 8:41:07 AM

Duchenne Muscular Dystrophy, a particularly severe form of muscular dystrophy [MD - a genetic disorder], affects as many as 15,000 young Americans. Many of those afflicted eventually succumb to cardiac or respiratory failure by their early 20’s. Researchers at University of California, Los Angeles, are utilizing stem cells to model the disease in order to develop and test treatments. One particularly promising treatment involves a method referred to as exon skipping. The technique essentially tricks the cell's machinery into misreading the MD genetic mutation so instead of producing the defective protein responsible for the disease, the cells produce a more functional version of the protein. In using muscle cells derived from stem cells of people with muscular dystrophy – the cells contain the mutation that causes muscular dystrophy - researchers anticipate their tests to more accurately reflect how human cells would react to their drugs [or combination of drugs]. This enables more efficient and effective testing of potential treatments and speeds the process of developing those treatment options that show the most promise. According to Dr. Stanley Nelson, a lead researcher on the project, “We are thrilled that stem cell research will change the outcome of Duchenne”.

Read More

Topics: Muscular Dystrophy, stemsaveblog, Brain, Duchenne Muscular Dystrophy, Stemcells

Researchers Pursue Stem Cell Treatment for Muscular Dystrophy

Posted by Kelsey StemSave on Jul 9, 2012 6:00:19 AM

 

 

 

 

 

 

 

 

Researchers at San Raffaele Scientific Institute of Milan and University College London recently used a technique to implant genetically modified muscle cells into mice with muscular dystrophy. These mice were then able to perform more movement related actions, such as running longer on a treadmill, than mice who did not receive the treatment. “This technique may be useful in the future for treating limb-girdle muscular dystrophy and perhaps other forms of muscular dystrophy,” says leader of the study, Dr. Francesco Saverio Tedesco.

Read More

Topics: Muscular Dystrophy, stemsaveblog, Stemcells

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all